Investigational Drug Information for Afegostat
✉ Email this page to a colleague
What is the drug development status for Afegostat?
Afegostat is an investigational drug.
There have been 3 clinical trials for Afegostat.
The most recent clinical trial was a Phase 2 trial, which was initiated on May 11th 2009.
The most common disease conditions in clinical trials are Gaucher Disease and [disabled in preview]. The leading clinical trial sponsors are Amicus Therapeutics and [disabled in preview].
Summary for Afegostat
| US Patents | 0 |
| International Patents | 0 |
| US Patent Applications | 234 |
| WIPO Patent Applications | 87 |
| Japanese Patent Applications | 52 |
| Clinical Trial Progress | Phase 2 (2009-05-11) |
| Vendors | 0 |
Recent Clinical Trials for Afegostat
| Title | Sponsor | Phase |
|---|---|---|
| A Long-Term Extension Study of AT2101 (Afegostat Tartrate) in Type 1 Gaucher Patients | Amicus Therapeutics | Phase 2 |
| A Study of Oral AT2101 (Afegostat Tartrate) in Treatment-naive Patients With Gaucher Disease | Amicus Therapeutics | Phase 2 |
| A Study of AT2101 (Afegostat Tartrate) in Adult Patients With Type 1 Gaucher Disease Currently Receiving Enzyme Replacement Therapy | Amicus Therapeutics | Phase 2 |
Clinical Trial Summary for Afegostat
Top disease conditions for Afegostat
Top clinical trial sponsors for Afegostat
US Patents for Afegostat
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
